Skip to main content

-

FJCI-2015-26965

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprogram Subprograma Estatal de Formación
Call Juan de la Cierva Formación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre FUNDACION PARA LA INVESTIGACION E INNOVACION BIOSANITARIA EN EL PRINCIPADO DE ASTURIAS

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Interindividual epigenetic variability: Sound or noise?

  • Tejedor, Juan Ramón
  • Fraga, Mario F.
Interindividual variability is an inherent characteristic of biological systems. Whereas the underlying molecular sources of interindividual variability remain poorly understood, recent work by Ecker et al. (Ecker S, Chen L, Pancaldi V, Bagger FO, et al. 2017. Genome Biol 18: 18.) sheds light on the characterization of this phenomenon in a complex biological scenario. By combining data from the BLUEPRINT Epigenome Project with a novel analytical approach, these authors were able to measure the degree of transcriptional and epigenetic variability across a wide panel of samples and types of immune cell. Interestingly, neutrophils displayed increased variability compared to monocytes and T cells, which may be related to the crucial role of the former as an initial mediator of immune responses. Here we review recent literature in this area, and discuss some important issues raised by these innovative analyses. Furthermore, we summarize other potential sources of epigenetic variability, such as epigenetic drift and the epigenetic clock, as well as the current ongoing direction of the field., We are also grateful for funding support from the Plan Nacional de I+D+I 2013‐2016/FEDER (PI15/00892 to M.F.F.) and the Asturias Regional Government (GRUPIN14‐052 to M.F.F.). The IUOPA is supported by the Obra Social Cajastur, Spain. JRT is supported by the Ministry of Economy and Competitiveness through a Juan de la Cierva postdoctoral fellowship (FJCI‐2015‐26965)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Distinct chromatin signatures of DNA hypomethylation in aging and cancer

  • Pérez, Raúl F.
  • Tejedor, Juan Ramón
  • Bayón, Gustavo F.
  • Fernández, Agustín F.
  • Fraga, Mario F.
Cancer is an aging-associated disease, but the underlying molecular links between these processes are still largely unknown. Gene promoters that become hypermethylated in aging and cancer share a common chromatin signature in ES cells. In addition, there is also global DNA hypomethylation in both processes. However, the similarity of the regions where this loss of DNA methylation occurs is currently not well characterized, and it is unknown if such regions also share a common chromatin signature in aging and cancer. To address this issue, we analyzed TCGA DNA methylation data from a total of 2,311 samples, including control and cancer cases from patients with breast, kidney, thyroid, skin, brain, and lung tumors and healthy blood, and integrated the results with histone, chromatin state, and transcription factor binding site data from the NIH Roadmap Epigenomics and ENCODE projects. We identified 98,857 CpG sites differentially methylated in aging and 286,746 in cancer. Hyper- and hypomethylated changes in both processes each had a similar genomic distribution across tissues and displayed tissue-independent alterations. The identified hypermethylated regions in aging and cancer shared a similar bivalent chromatin signature. In contrast, hypomethylated DNA sequences occurred in very different chromatin contexts. DNA hypomethylated sequences were enriched at genomic regions marked with the activating histone posttranslational modification H3K4me1 in aging, while in cancer, loss of DNA methylation was primarily associated with the repressive H3K9me3 mark. Our results suggest that the role of DNA methylation as a molecular link between aging and cancer is more complex than previously thought., This work was supported by the Plan Nacional de I+D+I [2013‐2016/FEDER PI15/00892 to M.F.F. and A.F.F., 2008‐2011/FEDER CP11/00131 to A.F.F.]; the ISCIII‐Subdirección General de Evaluación y Fomento de la Investigación [Miguel Servet contract CP11/00131 to A.F.F.]; Instituto Universitario de Oncología del Principado de Asturias (IUOPA) to [G.F.B.]; Fundación Ramón Areces to [M.F.F.]; and the Asturias Regional Government [GRUPIN14‐052 to M.F.F.]. R.F.P. is supported by the Retención de Jóvenes Talentos Fellowship from the Obra Social Cajastur‐Liberbank. J.R.T. is supported by the Ministry of Economy and Competitiveness Through a Juan de la Cierva Postdoctoral Fellowship [FJCI‐2015‐26965]. The IUOPA is supported by the Obra Social Cajastur‐Liberbank, Spain., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

DNA methylation reprogramming of human cancer cells by expression of a plant 5-methylcytosine DNA glycosylase

  • Morales-Ruiz, Teresa
  • García-Ortiz, María Victoria
  • Devesa-Guerra, Iván
  • Raya-Ruiz, Laura
  • Tejedor, Juan Ramón
  • Bayón, Gustavo F.
  • Sierra, Marta I.
  • Fraga, Mario F.
  • Ariza, Rafael R.
  • Roldán-Arjona, Teresa
Patterns of DNA methylation, an important epigenetic modification involved in gene silencing and development, are disrupted in cancer cells. Understanding the functional significance of aberrant methylation in tumors remains challenging, due in part to the lack of suitable tools to actively modify methylation patterns. DNA demethylation caused by mammalian DNA methyltransferase inhibitors is transient and replication-dependent, whereas that induced by TET enzymes involves oxidized 5mC derivatives that perform poorly understood regulatory functions. Unlike animals, plants possess enzymes that directly excise unoxidized 5mC from DNA, allowing restoration of unmethylated C through base excision repair. Here, we show that expression of Arabidopsis 5mC DNA glycosylase DEMETER (DME) in colon cancer cells demethylates and reactivates hypermethylated silenced loci. Interestingly, DME expression causes genome-wide changes that include both DNA methylation losses and gains, and partially restores the methylation pattern observed in normal tissue. Furthermore, such methylome reprogramming is accompanied by altered cell cycle responses and increased sensibility to anti-tumor drugs, decreased ability to form colonospheres, and tumor growth impairment in vivo. Our study shows that it is possible to reprogram a human cancer DNA methylome by expression of a plant DNA demethylase., This work was supported by the Spanish Ministry of Science and Innovation and the European Regional Development Fund [BFU2016-80728-P to T.RA and Pre-doctoral Fellowship BES-2014-067690 to I.D.G]; Junta de Andalucía and the European Regional Development Fund [P11-CVI-7576 to T.RA]; Ministry of Economy and Competitiveness [Juan de la Cierva postdoctoral fellowship FJCI-2015-26965 to JRT]; the Plan Nacional de I+D+I 2013–2016/FEDER [PI15/00892 to M.F.F.]; Instituto Universitario de Oncología del Principado de Asturias [to G.F.B. and M.I.S.]; and the Asturias Regional Government [GRUPIN14-052 to M.F.F.]. The IUOPA is supported by the Obra Social Cajastur, Spain., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis

  • Carella, Antonella
  • Tejedor, Juan Ramón
  • García, María G.
  • Urdinguio, Rocío G.
  • Bayón, Gustavo F.
  • Sierra, Marta I.
  • López, Virginia
  • García-Toraño, Estela
  • Santamarina-Ojeda, Pablo
  • Pérez, Raúl F.
  • Bigot, Timothée
  • Mangas, Cristina
  • Corte-Torres, M. Daniela
  • Sáenz-de-Santa-María, Inés
  • Mollejo, Manuela
  • Meléndez, Bárbara
  • Astudillo, Aurora
  • Chiara, María-Dolores
  • Fernández, Agustín F.
  • Fraga, Mario F.
Loss of 5‐hydroxymethylcytosine (5hmC) has been associated with mutations of the ten–eleven translocation (TET) enzymes in several types of cancer. However, tumors with wild‐type TET genes can also display low 5hmC levels, suggesting that other mechanisms involved in gene regulation might be implicated in the decline of this epigenetic mark. Here we show that DNA hypermethylation and loss of DNA hydroxymethylation, as well as a marked reduction of activating histone marks in the TET3 gene, impair TET3 expression and lead to a genome‐wide reduction in 5hmC levels in glioma samples and cancer cell lines. Epigenetic drugs increased expression of TET3 in glioblastoma cells and ectopic overexpression of TET3 impaired in vitro cell growth and markedly reduced tumor formation in immunodeficient mice models. TET3 overexpression partially restored the genome‐wide patterns of 5hmC characteristic of control brain samples in glioblastoma cell lines, while elevated TET3 mRNA levels were correlated with better prognosis in glioma samples. Our results suggest that epigenetic repression of TET3 might promote glioblastoma tumorigenesis through the genome‐wide alteration of 5hmC., This work has been financially supported by the Plan Nacional de I+D+I 2013-2016/FEDER (PI15/00892 to M.F.F. and A.F.F.), the ISCIII-Subdirección General de Evaluación y Fomento de la Investigación (Miguel Servet contract CP11/00131 to A.F.F.); the Asturias Regional Government (GRUPIN14-052 to M.F.F.); FICYT (A.C. and M.G.); the Ministry of Economy and Competitiveness of Spain (J.R.T., Juan de la Cierva fellowship FJCI-2015-26965, V.L., Juan de la Cierva fellowship IJCI-2015-23316); Fundación Científica de la AECC (to R.G.U.); FINBA-ISPA (R.F.P.); IUOPA (G.F.B. and C.M.) and Fundación Ramón Areces (M.F.F.). A.F.F. is also financially supported by the Ministry of Economy and Competitiveness of Spain, the European Regional Development Fund (FEDER) and the Programa Retos de la Sociedad (RTC-2015-3393-1). The IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Longitudinal genome-wide DNA methylation analysis uncovers persistent early-life DNA methylation changes

  • Pérez, Raúl F.
  • Santamarina-Ojeda, Pablo
  • Tejedor, Juan Ramón
  • Urdinguio, Rocío G.
  • Álvarez-Pitti, Julio
  • Redon, Pau
  • Fernández, Agustín F.
  • Fraga, Mario F.
  • Lurbe, Empar
[Background] Early life is a period of drastic epigenetic remodeling in which the epigenome is especially sensitive to extrinsic and intrinsic influence. However, the epigenome-wide dynamics of the DNA methylation changes that occur during this period have not been sufficiently characterized in longitudinal studies., [Methods] To this end, we studied the DNA methylation status of more than 750,000 CpG sites using Illumina MethylationEPIC arrays on 33 paired blood samples from 11 subjects at birth and at 5 and 10 years of age, then characterized the chromatin context associated with these loci by integrating our data with histone, chromatin-state and enhancer-element external datasets, and, finally, validated our results through bisulfite pyrosequencing in two independent longitudinal cohorts of 18 additional subjects., [Results] We found abundant DNA methylation changes (110,726 CpG sites) during the first lustrum of life, while far fewer alterations were observed in the subsequent 5 years (460 CpG sites). However, our analysis revealed persistent DNA methylation changes at 240 CpG sites, indicating that there are genomic locations of considerable epigenetic change beyond immediate birth. The chromatin context of hypermethylation changes was associated with repressive genomic locations and genes with developmental and cell signaling functions, while hypomethylation changes were linked to enhancer regions and genes with immunological and mRNA and protein metabolism functions. Significantly, our results show that genes that suffer simultaneous hyper- and hypomethylation are functionally distinct from exclusively hyper- or hypomethylated genes, and that enhancer-associated methylation is different in hyper- and hypomethylation scenarios, with hypomethylation being more associated to epigenetic changes at blood tissue-specific enhancer elements., [Conclusions] These data show that epigenetic remodeling is dramatically reduced after the first 5 years of life. However, there are certain loci which continue to manifest DNA methylation changes, pointing towards a possible functionality beyond early development. Furthermore, our results deepen the understanding of the genomic context associated to hyper- or hypomethylation alterations during time, suggesting that hypomethylation of blood tissue-specific enhancer elements could be of importance in the establishment of functional states in blood tissue during early-life., This work has been fnancially supported by: Ministerio de Ciencia, Innovación y Universidades (Grant Numbers PI14/01781 and PI11/00144), Instituto de Salud Carlos III and cofnanced by the European Regional Development Fund (to EL); the Plan Nacional de I+D+I 2013–2016/FEDER (PI15/00892 to MFF and AFF); IUOPA-ISPA-FINBA (to RGU, RFP and PS); AF Fernández is supported by a Miguel Servet II fellowship (contract CPII16/00007); JR Tejedor is supported by the Ministry of Economy and Competitiveness through a Juan de la Cierva postdoctoral fellowship (FJCI-2015-26965); the IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

  • Urdinguio, Rocío G.
  • López, Virginia
  • Bayón, Gustavo F.
  • Díaz de la Guardia, Rafael
  • Sierra, Marta I.
  • García-Toraño, Estela
  • Pérez, Raúl F.
  • García, María G.
  • Carella, Antonella
  • Pruneda, Patricia C.
  • Prieto López, Cristina
  • Dmitrijeva, Marija
  • Santamarina-Ojeda, Pablo
  • Belmonte, Thalia
  • Mangas, Cristina
  • Diaconu, Elena
  • Ferrero, Cecilia
  • Tejedor, Juan Ramón
  • Fernández-Morera, Juan L.
  • Bravo, Cristina
  • Bueno, Clara
  • Sanjuan-Pla, Alejandra
  • Rodríguez López, Ramón María
  • Suárez-Álvarez, Beatriz
  • López-Larrea, Carlos
  • Bernal, Teresa
  • Colado, Enrique
  • Balbín, Milagros
  • García-Suarez, Olivia
  • Chiara, María-Dolores
  • Sáenz-de-Santa-María, Inés
  • Rodríguez Hernández, Francisco José
  • Pando-Sandoval, Ana
  • Rodrigo, Luis
  • Santos, Laura
  • Salas, Ana
  • Vallejo-Díaz, Jesús
  • Carrera, Ana C.
  • Rico, Daniel
  • Hernández-López, Inmaculada
  • Vayá, Amparo
  • Ricart, José M.
  • Seto, Edward
  • Sima-Teruel, Núria
  • Vaquero, Alejandro
  • Valledor, Luis
  • Cañal, María Jesús
  • Pisano, David G.
  • Graña-Castro, Osvaldo
  • Thomas, Tim
  • Voss, Anne K.
  • Menéndez, Pablo
  • Villar-Garea, Ana
  • Deutzmann, Rainer
  • Fernández, Agustín F.
  • Fraga, Mario F.
Histone H4 acetylation at Lysine 16 (H4K16ac) is a key epigenetic mark involved in gene regulation, DNA repair and chromatin remodeling, and though it is known to be essential for embryonic development, its role during adult life is still poorly understood. Here we show that this lysine is massively hyperacetylated in peripheral neutrophils. Genome-wide mapping of H4K16ac in terminally differentiated blood cells, along with functional experiments, supported a role for this histone post-translational modification in the regulation of cell differentiation and apoptosis in the hematopoietic system. Furthermore, in neutrophils, H4K16ac was enriched at specific DNA repeats. These DNA regions presented an accessible chromatin conformation and were associated with the cleavage sites that generate the 50 kb DNA fragments during the first stages of programmed cell death. Our results thus suggest that H4K16ac plays a dual role in myeloid cells as it not only regulates differentiation and apoptosis, but it also exhibits a non-canonical structural role in poising chromatin for cleavage at an early stage of neutrophil cell death., Plan Nacional de I+D+I co-funding FEDER [PI15/00892 and PI18/01527 to M.F.F. and A.F.F.; PI16/01318 and PI14/01244 to C.L.]; ISCIII-Subdireccion General de Evaluacion y Fomento de la Investigacion, and Plan Nacional de I+D+I 2008–2011/FEDER [CP11/00131 to A.F.F.]; IUOPA (to G.F.B. and M.I.S.); Fundacion Cientifica de la AECC (to R.G.U.); Ministry of Economy and Competitiveness Juan de la Cierva postdoctoral fellowships [FJCI-2015-26965 to J.R.T., IJCI-2015- 23316 to V.L.]; Fundacion Ramon Areces (to M.F.F); FICYT (to E.G.T., M.G.G., A.C.); Asturias Regional Government [GRUPIN14-052 to M.F.F.]; Gobierno del Principado de Asturias, PCTI-Plan de Ciencia, Tecnologia e Innovacion co-funding Fondos FEDER (grant number IDI/2018/146 to M.F.F. and IDI/2018/144 to C.L.); Deutsche Forschungsgemeinschaft (DFG) [SFB960 to A.V.G., R.D.]; European Research Council [CoG-2014-646903]; Spanish Ministry of Economy and Competitiveness [SAF-SAF2013-43065 to P.M.]; Asociacion Española Contra el Cancer [AECC-CI-2015]; FERO Foundation, and the ISCIII [PI14-01191 to C.B.]; P.M. acknowledges financial support from The Obra Social La Caixa Fundacio Josep Carreras and The Generalitat de Catalunya (SGR330). P.M. an investigator from the Spanish Cell Therapy cooperative network (TERCEL). The IUOPA is supported by the Obra Social Liberbank-Cajastur, Spain. Funding for open access charge: Plan Nacional de I+D+I co-funding FEDER [PI18/01527].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Conservation of aging and cancer epigenetic signatures across human and mouse

  • Pérez, Raúl F.
  • Tejedor, Juan Ramón
  • Santamarina-Ojeda, Pablo
  • López, Virginia
  • Urdinguio, Rocío G.
  • Villamañán, Lucía
  • Candiota, Ana Paula
  • Vidal Sarró, Noemí
  • Barradas, Marta
  • Fernández-Marcos, Pablo José
  • Serrano, Manuel
  • Fernández, Agustín F.
  • Fraga, Mario F.
Aging and cancer are two interrelated processes, with aging being a major risk factor for the development of cancer. Parallel epigenetic alterations have been described for both, although differences, especially within the DNA hypomethylation scenario, have also been recently reported. Although many of these observations arise from the use of mouse models, there is a lack of systematic comparisons of human and mouse epigenetic patterns in the context of disease. However, such comparisons are significant as they allow to establish the extent to which some of the observed similarities or differences arise from pre-existing species-specific epigenetic traits. Here, we have used reduced representation bisulfite sequencing to profile the brain methylomes of young and old, tumoral and nontumoral brain samples from human and mouse. We first characterized the baseline epigenomic patterns of the species and subsequently focused on the DNA methylation alterations associated with cancer and aging. Next, we described the functional genomic and epigenomic context associated with the alterations, and finally, we integrated our data to study interspecies DNA methylation levels at orthologous CpG sites. Globally, we found considerable differences between the characteristics of DNA methylation alterations in cancer and aging in both species. Moreover, we describe robust evidence for the conservation of the specific cancer and aging epigenomic signatures in human and mouse. Our observations point toward the preservation of the functional consequences of these alterations at multiple levels of genomic regulation. Finally, our analyses reveal a role for the genomic context in explaining disease- and species-specific epigenetic traits., This work was supported by the Spanish Association Against Cancer (PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) cofunding 2018-2022/FEDER (IDI/2018/146 to M.F.F.), Fundación General CSIC (0348_CIE_6_E to M.F.F.), and the Health Institute Carlos III (Plan Nacional de I + D+I) cofunding FEDER (PI15/00892 and PI18/01527 to M.F.F and A.F.F.). They also acknowledge support from the Ramón Areces Foundation (CIVP18A3891 to P.J.F.M.), the AECC (SIRTBIO to P.J.F.M.), the MICINN (SAF2017-85766-R to P.J.F.M.), a Ramón y Cajal fellowship (MICINN, RYC-2017-22335 to P.J.F.M.), and the European Commission ATTRACT project (777222 to A.P.C.). J.R.T. is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (FJCI-2015-26965). R.F.P. and P.S.O. are supported by the Severo Ochoa program (BP17-114 and BP17-165, respectively). R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (Health Institute Carlos III). L.V. was supported by the UAB Predoctoral training programme (PIF predoctoral fellowships). They also acknowledge support from the IMDEA Food Institute and IUOPA-ISPA-FINBA (the IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epigenetic deregulation of the histone methyltransferase KMT5B contributes to malignant transformation in glioblastoma

  • López, Virginia
  • Tejedor, Juan Ramón
  • Carella, Antonella
  • García, María G.
  • Santamarina-Ojeda, Pablo
  • Pérez, Raúl F.
  • Mangas, Cristina
  • Urdinguio, Rocío G.
  • Aranburu, Aitziber
  • Nava Martín, Daniel de la
  • Corte-Torres, M. Daniela
  • Astudillo, Aurora
  • Mollejo, Manuela
  • Meléndez, Bárbara
  • Fernández, Agustín F.
  • Fraga, Mario F.
Glioblastoma multiforme (GBM) is the most common and aggressive type of brain tumor in adulthood. Epigenetic mechanisms are known to play a key role in GBM although the involvement of histone methyltransferase KMT5B and its mark H4K20me2 has remained largely unexplored. The present study shows that DNA hypermethylation and loss of DNA hydroxymethylation is associated with KMT5B downregulation and genome-wide reduction of H4K20me2 levels in a set of human GBM samples and cell lines as compared with non-tumoral specimens. Ectopic overexpression of KMT5B induced tumor suppressor-like features in vitro and in a mouse tumor xenograft model, as well as changes in the expression of several glioblastoma-related genes. H4K20me2 enrichment was found immediately upstream of the promoter regions of a subset of deregulated genes, thus suggesting a possible role for KMT5B in GBM through the epigenetic modulation of key target cancer genes., This research was funded by the Health Institute Carlos III (Plan Nacional de I+D+I) cofounding FEDER (PI15/00892 and PI18/01527 to MF and AF); the Government of the Principality of Asturias PCTI-Plan de Ciencia, Tecnología e Innovación de Asturias co-funding 2018–2022/FEDER (IDI/2018/146 to MF); AECC (PROYE18061FERN to MF); FGCSIC (0348_CIE_6_E to MF); Severo Ochoa Program BP17-165 to PS-O and BP17-114 to RP); the Ministry of Economy and Competitiveness of Spain (VL, Juan de la Cierva fellowship IJCI-2015-23316; JT, Juan de la Cierva fellowship FJCI-2015-26965); FICYT (AC and MG); FINBA-ISPA (VL); and IUOPA (VL and CM). The IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLL-rearranged B cell acute lymphoblastic leukemia

  • Tejedor, Juan Ramón
  • Bueno, Clara
  • Vinyoles, Meritxell
  • Petazzi, Paolo
  • Agraz-Doblas, Antonio
  • Cobo, Isabel
  • Torres-Ruiz, Raúl
  • Bayón, Gustavo F.
  • Pérez, Raúl F.
  • López-Tamargo, Sara
  • Gutiérrez-Agüera, Francisco
  • Santamarina-Ojeda, Pablo
  • Ramírez-Orellana, Manuel
  • Bardini, Michela
  • Cazzaniga, Giovanni
  • Ballerini, Paola
  • Schneider, Paulina
  • Stam, Ronald W.
  • Varela, Ignacio
  • Fraga, Mario F.
  • Fernández, Agustín F.
  • Menéndez, Pablo
B cell acute lymphoblastic leukemia (B-ALL) is the most common childhood cancer. As predicted by its prenatal origin, infant B-ALL (iB-ALL) shows an exceptionally silent DNA mutational landscape, suggesting that alternative epigenetic mechanisms may substantially contribute to its leukemogenesis. Here, we have integrated genome-wide DNA methylome and transcriptome data from 69 patients with de novo MLL-rearranged leukemia (MLLr) and non-MLLr iB-ALL leukemia uniformly treated according to the Interfant-99/06 protocol. iB-ALL methylome signatures display a plethora of common and specific alterations associated with chromatin states related to enhancer and transcriptional control in normal hematopoietic cells. DNA methylation, gene expression, and gene coexpression network analyses segregated MLLr away from non-MLLr iB-ALL and identified a coordinated and enriched expression of the AP-1 complex members FOS and JUN and RUNX factors in MLLr iB-ALL, consistent with the significant enrichment of hypomethylated CpGs in these genes. Integrative methylome-transcriptome analysis identified consistent cancer cell vulnerabilities, revealed a robust iB-ALL–specific gene expression–correlating dmCpG signature, and confirmed an epigenetic control of AP-1 and RUNX members in reshaping the molecular network of MLLr iB-ALL. Finally, pharmacological inhibition or functional ablation of AP-1 dramatically impaired MLLr-leukemic growth in vitro and in vivo using MLLr-iB-ALL patient–derived xenografts, providing rationale for new therapeutic avenues in MLLr-iB-ALL., We thank CERCA/Generalitat de Catalunya (SGR180) and Fundació Josep Carreras-Obra Social la Caixa for their institutional support. Financial support for this work was obtained from the European Research Council (CoG-2014-646903 and PoC-2018-811220 to PM), the Spanish Ministry of Economy and Competitiveness (SAF-2019-108160-R and SAF2016-76758-R to PM and IV, respectively), the Spanish Association against cancer (AECC-CI-2015 and PROYE18061FERN to CB and MFF), the Fundación Uno entre Cienmil (to PM), the Health Institute Carlos III (ISCIII/FEDER, PI17/01028, PI15/00892, PI18/01527 to CB and AFF/MFF, respectively). We also acknowledge the Plan de Ciencia, Tecnología e Innovación from the Asturias Government cofunding 2018–2022/FEDER (IDI/2018/146to MFF). MFF also acknowledges funding from Fundación General CSIC (0348_CIE_6_E). PM also acknowledges financial support from Fundación Leo Messi. JRT and MV are supported by Juan de la Cierva fellowships by the Spanish Ministry of Science and Innovation (FJCI-2015-26965, IJC2018-36825-I, IJCI-2017-3317) and IUOPA-ISPA-FINBA (The IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain). RTR is supported by a fellowship from the AECC scientific foundation. RFP and PSO are supported by the Severo Ochoa program (BP17-114 and BP17-165, respectively)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Blood DNA methylation patterns in older adults with evolving dementia

  • Pérez, Raúl F.
  • Alba-Linares, Juan J.
  • Tejedor, Juan Ramón
  • Fernández, Agustín F.
  • Calero, Miguel
  • Román-Domínguez, Aurorra
  • Borrás, Consuelo
  • Viña, José
  • Ávila, Jesús
  • Medina, Miguel
  • Fraga, Mario F.
Dementia and cognitive disorders are major aging-associated pathologies. The prevalence and severity of these conditions are influenced by both genetic and environmental factors. Reflecting this, epigenetic alterations have been associated with each of these processes, especially at the level of DNA methylation, and such changes may help explain the observed interindividual variability in the development of the 2 pathologies. However, the importance of epigenetic alterations in explaining their etiology is unclear because little is known about the timing of when they appear. Here, using Illumina MethylationEPIC arrays, we have longitudinally analyzed the peripheral blood methylomes of cognitively healthy older adults (>70 year), some of whom went on to develop dementia while others stayed healthy. We have characterized 34 individuals at the prediagnosis stage and at a 4-year follow-up in the postdiagnosis stage (total n = 68). Our results show multiple DNA methylation alterations linked to dementia status, particularly at the level of differentially methylated regions. These loci are associated with several dementia-related genes, including PON1, AP2A2, MAGI2, POT1, ITGAX, PACSIN1, SLC2A8, and EIF4E. We also provide validation of the previously reported epigenetic alteration of HOXB6 and PM20D1. Importantly, we show that most of these regions are already altered in the prediagnosis stage of individuals who go on to develop dementia. In conclusion, our observations suggest that dementia-associated epigenetic patterns that have specific biological features are already present before diagnosis, and thus may be important in the design of epigenetic biomarkers for disease detection based on peripheral tissues., This work was supported by: the Spanish Association Against Cancer (grant number PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) cofunding 2018-2022/FEDER (grant number IDI/2018/146 to M.F.F.), the Fundación General CSIC (grant number 0348_CIE_6_E to M.F.F.) and the Health Institute Carlos III (Plan Nacional de I + D + I) cofunding FEDER (grant numbers PI15/00892, PI18/01527 to M.F.F. and A.F.F.). JRT is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (grant number FJCI-2015-26965). R.F.P. is supported by the Severo Ochoa program (grant number BP17-114). We also acknowledge support from the Institute of Oncology of Asturias (IUOPA, supported by Obra Social Cajastur Liberbank, Spain), the Health Research Institute of Asturias (ISPA-FINBA) and Consorcio Centro de Investigación Biomédica en Red (CIBERER-ISCIII)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

  • Urdinguio, Rocío G.|||0000-0003-2736-5758
  • López, Virginia|||0000-0002-0065-7999
  • Fernández Bayón, Gustavo|||0000-0002-0763-0473
  • Díaz de la Guardia, Rafael|||0000-0001-9568-6719
  • Sierra, Marta I.
  • García-Toraño, Estela
  • Pérez, Raúl F.|||0000-0003-4336-9898
  • García, María G.
  • Carella, Antonella
  • Pruneda, Patricia C.
  • Prieto, Cristina|||0000-0002-0812-8100
  • Dmitrijeva, Marija
  • Santamarina-Ojeda, Pablo|||0000-0002-7439-8467
  • Belmonte, Thalia|||0000-0003-1241-6073
  • Mangas, Cristina
  • Diaconu, Elena|||0000-0002-2115-4311
  • Ferrero, Cecilia
  • Tejedor, Juan Ramón|||0000-0002-4061-9698
  • Fernandez-Morera, Juan Luis|||0000-0003-1244-068X
  • Bravo, Cristina
  • Bueno, Clara|||0000-0003-1442-6216
  • Sanjuan-Pla, Alejandra
  • Rodríguez López, Ramón María|||0000-0002-6770-5123
  • Suárez-Álvarez, Beatriz|||0000-0002-3431-4206
  • López-Larrea, Carlos
  • Bernal, Teresa|||0000-0002-2338-513X
  • Colado, Enrique|||0000-0001-8675-8207
  • Balbín, Milagros|||0000-0001-5325-0407
  • García-Suarez, Olivia
  • Chiara, María Dolores|||0000-0002-1112-1583
  • Sáenz De Santa María, Inés|||0000-0002-1868-3001
  • Rodríguez, Francisco|||0000-0001-7909-932X
  • Pando-Sandoval, Ana|||0000-0002-7923-9107
  • Rodrigo-Sáez, Luis|||0000-0003-1717-9345
  • Santos, Laura|||0000-0002-6194-0683
  • Salas, Ana
  • Vallejo-Díaz, Jesús
  • Carrera, Ana C.
  • Rico, Daniel|||0000-0002-6561-2310
  • Hernández-López, Inmaculada
  • Vayá, Amparo
  • Ricart, José María
  • Seto, Edward
  • Sima, Núria|||0000-0003-4097-1402
  • Vaquero, Alejandro|||0000-0002-8735-4156
  • Valledor, Luís|||0000-0002-0636-365X
  • Cañal Villanueva, María Jesús Fátima|||0000-0002-1639-9672
  • Pisano, David|||0000-0002-4895-4124
  • Graña-Castro, Osvaldo
  • Thomas, Tim|||0000-0002-7623-8344
  • Voss, Anne Kathrin|||0000-0002-3853-9381
  • Menéndez Bujan, Pablo|||0000-0001-9372-1007
  • Villar-Garea, Ana|||0000-0001-8960-1635
  • Deutzmann, Rainer
  • Fernández, Agustín F.|||0000-0002-3792-4085
  • Fraga, Mario|||0000-0001-8450-2603
Histone H4 acetylation at Lysine 16 (H4K16ac) is a key epigenetic mark involved in gene regulation, DNA repair and chromatin remodeling, and though it is known to be essential for embryonic development, its role during adult life is still poorly understood. Here we show that this lysine is massively hyperacetylated in peripheral neutrophils. Genome-wide mapping of H4K16ac in terminally differentiated blood cells, along with functional experiments, supported a role for this histone post-translational modification in the regulation of cell differentiation and apoptosis in the hematopoietic system. Furthermore, in neutrophils, H4K16ac was enriched at specific DNA repeats. These DNA regions presented an accessible chromatin conformation and were associated with the cleavage sites that generate the 50 kb DNA fragments during the first stages of programmed cell death. Our results thus suggest that H4K16ac plays a dual role in myeloid cells as it not only regulates differentiation and apoptosis, but it also exhibits a non-canonical structural role in poising chromatin for cleavage at an early stage of neutrophil cell death.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Conservation of Aging and Cancer Epigenetic Signatures across Human and Mouse

  • Pérez, Raúl F.|||0000-0003-4336-9898
  • Tejedor, Juan Ramón|||0000-0002-4061-9698
  • Santamarina-Ojeda, Pablo|||0000-0002-7439-8467
  • Martínez, Virginia López
  • Urdinguio, Rocío G.|||0000-0003-2736-5758
  • Villamañán, Lucía
  • Candiota Silveira, Ana Paula|||0000-0002-1523-6505
  • Sarró, N. mí Vidal
  • Barradas, Marta
  • Fernandez-Marcos, Pablo Jose
  • Serrano, Manuel|||0000-0001-7177-9312
  • Fernández, Agustín F|||0000-0002-3792-4085
  • Fraga, Mario|||0000-0001-8450-2603
Aging and cancer are two interrelated processes, with aging being a major risk factor for the development of cancer. Parallel epigenetic alterations have been described for both, although differences, especially within the DNA hypomethylation scenario, have also been recently reported. Although many of these observations arise from the use of mouse models, there is a lack of systematic comparisons of human and mouse epigenetic patterns in the context of disease. However, such comparisons are significant as they allow to establish the extent to which some of the observed similarities or differences arise from pre-existing species-specific epigenetic traits. Here, we have used reduced representation bisulfite sequencing to profile the brain methylomes of young and old, tumoral and nontumoral brain samples from human and mouse. We first characterized the baseline epigenomic patterns of the species and subsequently focused on the DNA methylation alterations associated with cancer and aging. Next, we described the functional genomic and epigenomic context associated with the alterations, and finally, we integrated our data to study interspecies DNA methylation levels at orthologous CpG sites. Globally, we found considerable differences between the characteristics of DNA methylation alterations in cancer and aging in both species. Moreover, we describe robust evidence for the conservation of the specific cancer and aging epigenomic signatures in human and mouse. Our observations point toward the preservation of the functional consequences of these alterations at multiple levels of genomic regulation. Finally, our analyses reveal a role for the genomic context in explaining disease- and species-specific epigenetic traits.